Galera Therapeutics Inc. (NASDAQ: GRTX) started the day on April 30, 2021, with a price increase of 0.37% at $8.15. During the day, the stock rose to $8.22 and sunk to $7.70 before settling in for the price of $8.12 at the close. Taking a more long-term approach, GRTX posted a 52-week range of $6.15-$15.00.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -25.30%. This publicly-traded company’s shares outstanding now amounts to $24.96 million, simultaneously with a float of $21.96 million. The organization now has a market capitalization sitting at $205.14 million. At the time of writing, stock’s 50-day Moving Average stood at $9.41, while the 200-day Moving Average is $9.80.
Galera Therapeutics Inc. (GRTX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Galera Therapeutics Inc.’s current insider ownership accounts for 10.80%, in contrast to 76.40% institutional ownership. According to the most recent insider trade that took place on Feb 18, this organization’s 10% Owner sold 500,000 shares at the rate of 10.58, making the entire transaction reach 5,290,000 in total value, affecting insider ownership by 2,459,021. Preceding that transaction, on Nov 13, Company’s Director bought 2,325 for 10.22, making the whole transaction’s value amount to 23,771. This particular insider is now the holder of 6,325 in total.
Galera Therapeutics Inc. (GRTX) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported -$0.8 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.71) by -$0.09. This company achieved a return on equity of -196.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.88 per share during the current fiscal year.
Galera Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -25.30% and is forecasted to reach -2.60 in the upcoming year.
Galera Therapeutics Inc. (NASDAQ: GRTX) Trading Performance Indicators
Let’s observe the current performance indicators for Galera Therapeutics Inc. (GRTX). It’s Quick Ratio in the last reported quarter now stands at 5.60. The Stock has managed to achieve an average true range (ATR) of 0.83.
In the same vein, GRTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.98, a figure that is expected to reach -0.83 in the next quarter, and analysts are predicting that it will be -2.60 at the market close of one year from today.
Technical Analysis of Galera Therapeutics Inc. (GRTX)
If we take a close look at the recent performances of Galera Therapeutics Inc. (NASDAQ: GRTX), its last 5-days Average volume was 5.9 million that shows progress from its year to date volume of 0.43 million. During the previous 9 days, stock’s Stochastic %D was recorded 43.06% While, its Average True Range was 0.88.
Raw Stochastic average of Galera Therapeutics Inc. (GRTX) in the period of the previous 100 days is set at 29.24%, which indicates a major fall in contrast to 50.51% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 100.50% that was higher than 71.13% volatility it exhibited in the past 100-days period.